Tamar Bridge News is your trusted guide through the currents of UK news, committed to bridging the gap between information and insight with clarity, precision, and a human-centric approach.
The groundbreaking tinnitus treatment device, Lenire, has garnered significant attention following the publication of its pivotal clinical trial results in Nature Communications. This development marks a major milestone for Neuromod Devices, the creators of Lenire, as the device becomes the first and only bimodal neuromodulation therapy for tinnitus to receive approval from the US Food and Drug Administration (FDA). Tinnitus, commonly referred to as ‘ringing in the ears,’ is a complex neurological condition characterised by the perception of sound without an external source. Affecting an estimated 25 million Americans, it remains the most prevalent service-connected disability compensated by the US…